Autogenous Demineralized Dentin Block Graft Versus Autogenous Bone Block Graft for Alveolar Ridge Preservation

Sponsor
Cairo University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05347017
Collaborator
(none)
20
1
2
13
1.5

Study Details

Study Description

Brief Summary

The aim of this trial is to compare the effect of autogenous demineralized dentin block graft (ADDBG) versus autogenous bone block graft (ABBG) harvested from maxillary tuberosity on alveolar ridge preservation after extraction of non-restorable single rooted teeth

Condition or Disease Intervention/Treatment Phase
  • Procedure: Alveolar ridge preservation using autogenous demineralized dentin block graft
  • Procedure: Alveolar ridge preservation using autogenous bone block graft
N/A

Detailed Description

Many studies have reported an approximately 50% reduction in alveolar bone both the horizontal and vertical directions over 12 months with more than two-thirds of the reduction occurring in the first three months after extraction. Alveolar ridge preservation is a procedure that attempts to reduce bone dimensional changes that naturally take place following tooth extraction. A broadly recognized approach is the maintenance of bone walls through bone substitute (graft) delivery into the socket, where guided bone regeneration may be a requisite. Autogenous bone graft has osteogenic and osteoinductive effect. however, when attempts were made to use autologous bone chips in socket preservation, they failed to promote healing or stimulate hard tissue formation in the socket. On the other hand, autogenous bone block graft from the tuberosity has shown a feasible, user-friendly, low-cost solution for minimizing soft and hard tissue collapse and dimensional loss following single-rooted tooth extraction.

Moreover, root dentin block is composed of Type I collagen matrix with several osteoinductive non-collagenous proteins such as bone morphogenetic proteins (BMP) and dentin matrix proteins. Geometrically, alveolar bone morphology was maintained by dentin block graft as well as it has micropores (dentinal tubules) of 3-5 μm diameter and macropores of 0.2-0.3 mm diameter for enhancing osteoinductive and osteoconductive functions.

Both demineralized dentin block and autogenous bone block grafts has been utilized for alveolar ridge preservation or augmentation but the superiority of one form over the other is not yet clear

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Effect of Autogenous Demineralized Dentin Block Graft Versus Autogenous Bone Block Graft on Alveolar Ridge Preservation: A Randomized Controlled Clinical Trial
Anticipated Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Jan 1, 2023
Anticipated Study Completion Date :
Jul 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Alveolar ridge preservation using autogenous demineralized dentin block graft

Atraumatic extraction of non-restorable teeth, then the extracted tooth will be prepared and demineralized using HCL acid as demineralized dentin block graft and inserted in the extraction socket

Procedure: Alveolar ridge preservation using autogenous demineralized dentin block graft
Atraumatic extraction of non restorable tooth, then the extracted tooth will be prepared and demineralized by HCL acid and inserted as demineralized dentin block graft in the socket

Active Comparator: Alveolar ridge preservation using autogenous bone block graft

Atraumatic extraction of non-restorable teeth, then autogenous bone block will be harvested from the maxillary tuberosity and reshaped and inserted in the extraction socket

Procedure: Alveolar ridge preservation using autogenous bone block graft
Atraumatic extraction of non restorable tooth, then the autogenous bone block graft will be harvested from the maxillary tuberosity and reshaped and inserted into the socket

Outcome Measures

Primary Outcome Measures

  1. Alveolar ridge bucco-lingual width change in mm [6 months]

    Alveolar bone linear width will be measured at baseline and after 6 months using cone beam computed tomography (CBCT) scans. The change in bone width will be calculated as the subtraction of final width from baseline width and will be measured in millimetres (Jung et al., 2013)

Secondary Outcome Measures

  1. Alveolar ridge apico-coronal height change in mm [6 months]

    Difference in height linear measurement between baseline and final CBCT scans (Jung et al., 2013) Difference in height linear measurement between baseline and final CBCT scans (Jung et al., 2013) Measures the difference in height linear measurements between baseline and final CBCT scans (Jung et al., 2013)

  2. Histological assessment [6 months]

    Bone samples from control and intervention sites will be taken during implant placement using a trephine bur of a size smaller than the implant. Samples will be examined for new bone formation (Yes/no) and inflammatory response (Yes/no) (Wong and Rabie, 2010).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Non-restorable tooth indicated for extraction

  • Single-rooted teeth

  • Motivated patients, agree to sign informed consent and complete the follow-up period

Exclusion Criteria:
  • Pregnant females

  • active infection at extraction site

  • Smokers

  • systemic conditions affecting healing (e.g. diabetes, medications as bisphosphonates...)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of dentistry Cairo Egypt

Sponsors and Collaborators

  • Cairo University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Mohamed Talaat Mohamed Mahmoud El Behwashy, Principal Investigator. Mohamed Elbehwashy, Cairo University
ClinicalTrials.gov Identifier:
NCT05347017
Other Study ID Numbers:
  • perio2022april
First Posted:
Apr 26, 2022
Last Update Posted:
May 2, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 2, 2022